Biomathematica SAS

BioMathematica is building the new standard in the microbiome field: an online platform called the DryLab processing and integrating microbiome-related ‘omics’ data for condition specific, personalised microbiome models in healthy and disease states. Using Artificial Intelligence and genome-scale metabolic modelling, this platform is used by biotech and pharma companies for data analysis and diet–microbiome, microbe–microbe and host–microbe interactions simulations. The platform is dedicated to the development of personalised nutrition, prebiotics/probiotics/synbiotics and therapeutics design and optimization.

COMPANY PEOPLE

Sebastien Forcioli

Sebastien Forcioli
Co-Founder @ Biomathematica SAS

Ghjuvan Grimaud

Ghjuvan Grimaud
CEO & Co-Founder @ Biomathematica SAS

YOU MIGHT ALSO BE INTERESTED IN

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision.  Except as expressly stated by SOSV in writing, neither the SOSV website nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities.